The US Food and Drug Administration (FDA)’s denial of premarket tobacco product applications (PMTAs) has been mostly welcomed by politicians and public health organisations – some of whom have urged the agency to deny Juul Labs’ application too.
US senator Dick Durbin of Illinois said he was glad to hear that the federal agency had rejected most of the applications but said it was “unacceptable” that the evaluation of Juul products had been postponed.
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.
LATEST ALERTS
